These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 9587077)
1. Altered fractionation in the management of head and neck cancer. Ang KK Int J Radiat Biol; 1998 Apr; 73(4):395-9. PubMed ID: 9587077 [TBL] [Abstract][Full Text] [Related]
2. Altered fractionation trials in head and neck cancer. Ang KK Semin Radiat Oncol; 1998 Oct; 8(4):230-6. PubMed ID: 9873100 [TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for cancer of the head and neck: altered fractionation regimens. Nguyen LN; Ang KK Lancet Oncol; 2002 Nov; 3(11):693-701. PubMed ID: 12424072 [TBL] [Abstract][Full Text] [Related]
4. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966 [TBL] [Abstract][Full Text] [Related]
5. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243 [TBL] [Abstract][Full Text] [Related]
6. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530 [TBL] [Abstract][Full Text] [Related]
7. A systematic overview of radiation therapy effects in head and neck cancer. Zackrisson B; Mercke C; Strander H; Wennerberg J; Cavallin-Ståhl E Acta Oncol; 2003; 42(5-6):443-61. PubMed ID: 14596506 [TBL] [Abstract][Full Text] [Related]
8. Altered fractionation for head and neck cancer. Garden AS Oncology (Williston Park); 2001 Oct; 15(10):1326-32, 1334; discussion 1334, 1339-41. PubMed ID: 11702960 [TBL] [Abstract][Full Text] [Related]
9. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002 [TBL] [Abstract][Full Text] [Related]
10. Benefits of accelerated hyperfractionation for head and neck cancer. Cummings BJ Acta Oncol; 1999; 38(2):131-6. PubMed ID: 10227432 [TBL] [Abstract][Full Text] [Related]
11. Hyperfractionated or accelerated radiotherapy for head and neck cancer. Baujat B; Bourhis J; Blanchard P; Overgaard J; Ang KK; Saunders M; Le Maître A; Bernier J; Horiot JC; Maillard E; Pajak TF; Poulsen MG; Bourredjem A; O'Sullivan B; Dobrowsky W; Andrzej H; Skladowski K; Hay JH; Pinto LH; Fu KK; Fallai C; Sylvester R; Pignon JP; Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD002026. PubMed ID: 21154350 [TBL] [Abstract][Full Text] [Related]
12. Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials. Stuschke M; Thames HD Radiother Oncol; 1999 May; 51(2):113-21. PubMed ID: 10435801 [TBL] [Abstract][Full Text] [Related]
13. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Khalil AA; Bentzen SM; Bernier J; Saunders MI; Horiot JC; Van Den Bogaert W; Cummings BJ; Dische S Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):568-75. PubMed ID: 12573743 [TBL] [Abstract][Full Text] [Related]
15. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Bentzen SM; Saunders MI; Dische S Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202 [TBL] [Abstract][Full Text] [Related]
16. Randomized trials on altered fractionation in head and neck cancer radiotherapy with conventional fractionation as control arm: another lap to go. Olmi P; Fallai C Tumori; 1998; 84(2):160-6. PubMed ID: 9620240 [TBL] [Abstract][Full Text] [Related]
17. Altered fractionation in definitive irradiation of squamous cell carcinoma of the head and neck. Mendenhall WM; Amdur RJ; Siemann DW; Parsons JT Curr Opin Oncol; 2000 May; 12(3):207-14. PubMed ID: 10841192 [TBL] [Abstract][Full Text] [Related]
18. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck. Mendenhall WM; Parsons JT Cancer Invest; 1998; 16(8):594-603. PubMed ID: 9844620 [TBL] [Abstract][Full Text] [Related]
19. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer. Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514 [TBL] [Abstract][Full Text] [Related]
20. Altered fractionation: limited by mucosal reactions? Kaanders JH; van der Kogel AJ; Ang KK Radiother Oncol; 1999 Mar; 50(3):247-60. PubMed ID: 10392810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]